[
    {
        "Type of cases ": "NSP Cured",
        "I Qtr 2019": "197",
        "II Qtr 2019": "225",
        "III Qtr 2019": "145",
        "IV Qtr 2019": "150",
        "Total 2019": "717",
        "%": "88.5"
    },
    {
        "Type of cases ": "NSP Treatment completed",
        "I Qtr 2019": "0",
        "II Qtr 2019": "0",
        "III Qtr 2019": "0",
        "IV Qtr 2019": "2",
        "Total 2019": "2",
        "%": "0.2"
    },
    {
        "Type of cases ": "NSP Died",
        "I Qtr 2019": "8",
        "II Qtr 2019": "7",
        "III Qtr 2019": "2",
        "IV Qtr 2019": "8",
        "Total 2019": "25",
        "%": "3.1"
    },
    {
        "Type of cases ": "NSP Failure",
        "I Qtr 2019": "3",
        "II Qtr 2019": "4",
        "III Qtr 2019": "1",
        "IV Qtr 2019": "2",
        "Total 2019": "10",
        "%": "1.2"
    },
    {
        "Type of cases ": "NSP Lost to Follow-up",
        "I Qtr 2019": "4",
        "II Qtr 2019": "4",
        "III Qtr 2019": "8",
        "IV Qtr 2019": "4",
        "Total 2019": "20",
        "%": "2.5"
    },
    {
        "Type of cases ": "NSP Not Evaluated",
        "I Qtr 2019": "0",
        "II Qtr 2019": "3",
        "III Qtr 2019": "3",
        "IV Qtr 2019": "1",
        "Total 2019": "7",
        "%": "0.9"
    },
    {
        "Type of cases ": "NSP Treatment Regimen Changed",
        "I Qtr 2019": "4",
        "II Qtr 2019": "11",
        "III Qtr 2019": "7",
        "IV Qtr 2019": "7",
        "Total 2019": "29",
        "%": "3.6"
    },
    {
        "Type of cases ": "NSP Total",
        "I Qtr 2019": "216",
        "II Qtr 2019": "254",
        "III Qtr 2019": "166",
        "IV Qtr 2019": "174",
        "Total 2019": "810",
        "%": ""
    },
    {
        "Type of cases ": "NSN/NEP Cured",
        "I Qtr 2019": "0",
        "II Qtr 2019": "0",
        "III Qtr 2019": "0",
        "IV Qtr 2019": "0",
        "Total 2019": "0",
        "%": "0.0"
    },
    {
        "Type of cases ": "NSN/NEP Treatment completed",
        "I Qtr 2019": "316",
        "II Qtr 2019": "370",
        "III Qtr 2019": "303",
        "IV Qtr 2019": "249",
        "Total 2019": "1238",
        "%": "95.3"
    },
    {
        "Type of cases ": "NSN/NEP Died",
        "I Qtr 2019": "12",
        "II Qtr 2019": "3",
        "III Qtr 2019": "7",
        "IV Qtr 2019": "5",
        "Total 2019": "27",
        "%": "2.1"
    },
    {
        "Type of cases ": "NSN/NEP Failure",
        "I Qtr 2019": "3",
        "II Qtr 2019": "1",
        "III Qtr 2019": "0",
        "IV Qtr 2019": "0",
        "Total 2019": "4",
        "%": "0.3"
    },
    {
        "Type of cases ": "NSN/NEP Lost to Follow-up",
        "I Qtr 2019": "5",
        "II Qtr 2019": "7",
        "III Qtr 2019": "2",
        "IV Qtr 2019": "2",
        "Total 2019": "16",
        "%": "1.2"
    },
    {
        "Type of cases ": "NSN/NEP Not Evaluated",
        "I Qtr 2019": "1",
        "II Qtr 2019": "1",
        "III Qtr 2019": "1",
        "IV Qtr 2019": "1",
        "Total 2019": "4",
        "%": "0.3"
    },
    {
        "Type of cases ": "NSN/NEP Treatment Regimen Changed",
        "I Qtr 2019": "4",
        "II Qtr 2019": "3",
        "III Qtr 2019": "3",
        "IV Qtr 2019": "0",
        "Total 2019": "10",
        "%": "0.8"
    },
    {
        "Type of cases ": "NSN/NEP Total",
        "I Qtr 2019": "341",
        "II Qtr 2019": "385",
        "III Qtr 2019": "316",
        "IV Qtr 2019": "257",
        "Total 2019": "1299",
        "%": ""
    },
    {
        "Type of cases ": "RT +ve Cured",
        "I Qtr 2019": "79",
        "II Qtr 2019": "53",
        "III Qtr 2019": "54",
        "IV Qtr 2019": "44",
        "Total 2019": "230",
        "%": "82.1"
    },
    {
        "Type of cases ": "RT+ve Treatment completed",
        "I Qtr 2019": "0",
        "II Qtr 2019": "0",
        "III Qtr 2019": "0",
        "IV Qtr 2019": "0",
        "Total 2019": "0",
        "%": "0.0"
    },
    {
        "Type of cases ": "RT +Ve Died",
        "I Qtr 2019": "4",
        "II Qtr 2019": "4",
        "III Qtr 2019": "2",
        "IV Qtr 2019": "2",
        "Total 2019": "12",
        "%": "4.3"
    },
    {
        "Type of cases ": "RT +ve Failure",
        "I Qtr 2019": "4",
        "II Qtr 2019": "2",
        "III Qtr 2019": "2",
        "IV Qtr 2019": "4",
        "Total 2019": "12",
        "%": "4.3"
    },
    {
        "Type of cases ": "RT +ve Lost to Follow-up",
        "I Qtr 2019": "4",
        "II Qtr 2019": "3",
        "III Qtr 2019": "5",
        "IV Qtr 2019": "2",
        "Total 2019": "14",
        "%": "5"
    },
    {
        "Type of cases ": "RT +ve Not Evaluated",
        "I Qtr 2019": "0",
        "II Qtr 2019": "1",
        "III Qtr 2019": "0",
        "IV Qtr 2019": "1",
        "Total 2019": "2",
        "%": "0.7"
    },
    {
        "Type of cases ": "RT +ve Treatment Regimen Changed",
        "I Qtr 2019": "4",
        "II Qtr 2019": "3",
        "III Qtr 2019": "3",
        "IV Qtr 2019": "0",
        "Total 2019": "10",
        "%": "3.6"
    },
    {
        "Type of cases ": "RT +ve Total",
        "I Qtr 2019": "95",
        "II Qtr 2019": "66",
        "III Qtr 2019": "66",
        "IV Qtr 2019": "53",
        "Total 2019": "280",
        "%": ""
    },
    {
        "Type of cases ": "RT Neg Cured",
        "I Qtr 2019": "0",
        "II Qtr 2019": "0",
        "III Qtr 2019": "0",
        "IV Qtr 2019": "0",
        "Total 2019": "0",
        "%": "0.0"
    },
    {
        "Type of cases ": "RT Neg Treatment completed",
        "I Qtr 2019": "44",
        "II Qtr 2019": "71",
        "III Qtr 2019": "49",
        "IV Qtr 2019": "38",
        "Total 2019": "202",
        "%": "91.8"
    },
    {
        "Type of cases ": "RT Neg Died",
        "I Qtr 2019": "2",
        "II Qtr 2019": "3",
        "III Qtr 2019": "3",
        "IV Qtr 2019": "3",
        "Total 2019": "11",
        "%": "5"
    },
    {
        "Type of cases ": "RT Neg Failure",
        "I Qtr 2019": "0",
        "II Qtr 2019": "0",
        "III Qtr 2019": "0",
        "IV Qtr 2019": "1",
        "Total 2019": "1",
        "%": "0.5"
    },
    {
        "Type of cases ": "RT Neg Lost to Follow-up",
        "I Qtr 2019": "0",
        "II Qtr 2019": "0",
        "III Qtr 2019": "3",
        "IV Qtr 2019": "2",
        "Total 2019": "5",
        "%": "2.3"
    },
    {
        "Type of cases ": "RT Neg Not Evaluated",
        "I Qtr 2019": "0",
        "II Qtr 2019": "0",
        "III Qtr 2019": "0",
        "IV Qtr 2019": "0",
        "Total 2019": "0",
        "%": "0.0"
    },
    {
        "Type of cases ": "RT Neg Treatment Regimen Changed",
        "I Qtr 2019": "0",
        "II Qtr 2019": "0",
        "III Qtr 2019": "1",
        "IV Qtr 2019": "0",
        "Total 2019": "1",
        "%": "0.5"
    },
    {
        "Type of cases ": "RT Neg Total",
        "I Qtr 2019": "46",
        "II Qtr 2019": "74",
        "III Qtr 2019": "56",
        "IV Qtr 2019": "44",
        "Total 2019": "220",
        "%": ""
    }
]